Cargando…

Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most lethal malignancies in the world. Patients with HCC choose postoperative adjuvant transarterial chemoembolization (PA-TACE) after surgical resection to reduce the risk of recurrence. However, many of them have recurrence within a short pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cong, Liu, Jian, Gu, Zhuxin, Sun, Yanjun, Lu, Wenwu, Liu, Xiaokan, Chen, Kang, Ma, Tianzhi, Zhao, Suming, Zhao, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422964/
https://www.ncbi.nlm.nih.gov/pubmed/37576612
http://dx.doi.org/10.2147/JHC.S423129
_version_ 1785089342635507712
author Chen, Cong
Liu, Jian
Gu, Zhuxin
Sun, Yanjun
Lu, Wenwu
Liu, Xiaokan
Chen, Kang
Ma, Tianzhi
Zhao, Suming
Zhao, Hui
author_facet Chen, Cong
Liu, Jian
Gu, Zhuxin
Sun, Yanjun
Lu, Wenwu
Liu, Xiaokan
Chen, Kang
Ma, Tianzhi
Zhao, Suming
Zhao, Hui
author_sort Chen, Cong
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most lethal malignancies in the world. Patients with HCC choose postoperative adjuvant transarterial chemoembolization (PA-TACE) after surgical resection to reduce the risk of recurrence. However, many of them have recurrence within a short period. METHODS: In this retrospective analysis, a total of 173 patients who underwent PA-TACE between September 2016 and March 2020 were recruited. Radiomic features were derived from the arterial and venous phases of each patient. Early recurrence (ER)-related radiomics features of HCC and the spleen were selected to build two rad-scores using the least absolute shrinkage and selection operator (LASSO) Cox regression analysis. Logistic regression was applied to establish the Radiation (Rad)_score by combining the two regions. We constructed a nomogram containing clinical information and dual-region rad-scores, which was evaluated in terms of discrimination, calibration, and clinical usefulness. RESULTS: All three radiological scores showed good performance for ER prediction. The combined Rad_score performed the best, with an area under the curve (AUC) of 0.853 (95% confidence interval [CI], 0.783–0.908) in the training set and 0.929 (95% CI, 0.789–0.988) in the validation set. Multivariate analysis identified total bilirubin (TBIL) and the combined Rad_score as independent prognostic factors for ER. The nomogram was found to be clinically valuable, as determined by the decision curves (DCA) and clinical impact curves (CIC). CONCLUSION: A multimodal dual-region radiomics model combining HCC and the spleen is an independent prognostic tool for ER. The combination of dual-region radiomics features and clinicopathological factors has a good clinical application value.
format Online
Article
Text
id pubmed-10422964
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104229642023-08-13 Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization Chen, Cong Liu, Jian Gu, Zhuxin Sun, Yanjun Lu, Wenwu Liu, Xiaokan Chen, Kang Ma, Tianzhi Zhao, Suming Zhao, Hui J Hepatocell Carcinoma Original Research BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most lethal malignancies in the world. Patients with HCC choose postoperative adjuvant transarterial chemoembolization (PA-TACE) after surgical resection to reduce the risk of recurrence. However, many of them have recurrence within a short period. METHODS: In this retrospective analysis, a total of 173 patients who underwent PA-TACE between September 2016 and March 2020 were recruited. Radiomic features were derived from the arterial and venous phases of each patient. Early recurrence (ER)-related radiomics features of HCC and the spleen were selected to build two rad-scores using the least absolute shrinkage and selection operator (LASSO) Cox regression analysis. Logistic regression was applied to establish the Radiation (Rad)_score by combining the two regions. We constructed a nomogram containing clinical information and dual-region rad-scores, which was evaluated in terms of discrimination, calibration, and clinical usefulness. RESULTS: All three radiological scores showed good performance for ER prediction. The combined Rad_score performed the best, with an area under the curve (AUC) of 0.853 (95% confidence interval [CI], 0.783–0.908) in the training set and 0.929 (95% CI, 0.789–0.988) in the validation set. Multivariate analysis identified total bilirubin (TBIL) and the combined Rad_score as independent prognostic factors for ER. The nomogram was found to be clinically valuable, as determined by the decision curves (DCA) and clinical impact curves (CIC). CONCLUSION: A multimodal dual-region radiomics model combining HCC and the spleen is an independent prognostic tool for ER. The combination of dual-region radiomics features and clinicopathological factors has a good clinical application value. Dove 2023-08-08 /pmc/articles/PMC10422964/ /pubmed/37576612 http://dx.doi.org/10.2147/JHC.S423129 Text en © 2023 Chen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chen, Cong
Liu, Jian
Gu, Zhuxin
Sun, Yanjun
Lu, Wenwu
Liu, Xiaokan
Chen, Kang
Ma, Tianzhi
Zhao, Suming
Zhao, Hui
Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization
title Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization
title_full Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization
title_fullStr Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization
title_full_unstemmed Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization
title_short Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization
title_sort integration of multimodal computed tomography radiomic features of primary tumors and the spleen to predict early recurrence in patients with postoperative adjuvant transarterial chemoembolization
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422964/
https://www.ncbi.nlm.nih.gov/pubmed/37576612
http://dx.doi.org/10.2147/JHC.S423129
work_keys_str_mv AT chencong integrationofmultimodalcomputedtomographyradiomicfeaturesofprimarytumorsandthespleentopredictearlyrecurrenceinpatientswithpostoperativeadjuvanttransarterialchemoembolization
AT liujian integrationofmultimodalcomputedtomographyradiomicfeaturesofprimarytumorsandthespleentopredictearlyrecurrenceinpatientswithpostoperativeadjuvanttransarterialchemoembolization
AT guzhuxin integrationofmultimodalcomputedtomographyradiomicfeaturesofprimarytumorsandthespleentopredictearlyrecurrenceinpatientswithpostoperativeadjuvanttransarterialchemoembolization
AT sunyanjun integrationofmultimodalcomputedtomographyradiomicfeaturesofprimarytumorsandthespleentopredictearlyrecurrenceinpatientswithpostoperativeadjuvanttransarterialchemoembolization
AT luwenwu integrationofmultimodalcomputedtomographyradiomicfeaturesofprimarytumorsandthespleentopredictearlyrecurrenceinpatientswithpostoperativeadjuvanttransarterialchemoembolization
AT liuxiaokan integrationofmultimodalcomputedtomographyradiomicfeaturesofprimarytumorsandthespleentopredictearlyrecurrenceinpatientswithpostoperativeadjuvanttransarterialchemoembolization
AT chenkang integrationofmultimodalcomputedtomographyradiomicfeaturesofprimarytumorsandthespleentopredictearlyrecurrenceinpatientswithpostoperativeadjuvanttransarterialchemoembolization
AT matianzhi integrationofmultimodalcomputedtomographyradiomicfeaturesofprimarytumorsandthespleentopredictearlyrecurrenceinpatientswithpostoperativeadjuvanttransarterialchemoembolization
AT zhaosuming integrationofmultimodalcomputedtomographyradiomicfeaturesofprimarytumorsandthespleentopredictearlyrecurrenceinpatientswithpostoperativeadjuvanttransarterialchemoembolization
AT zhaohui integrationofmultimodalcomputedtomographyradiomicfeaturesofprimarytumorsandthespleentopredictearlyrecurrenceinpatientswithpostoperativeadjuvanttransarterialchemoembolization